Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Corin Group is an established, global orthopaedic medical device company that has evolved from a traditional implant manufacturer into a technology-integrated solutions provider. Its core strategy combines clinically proven implants with the Apollo robotic-assisted surgery platform, which features AI-driven preoperative planning, intraoperative robotic guidance, and cloud-based data analytics for continuous learning. This unique integration aims to deliver personalized, balanced joint replacements, improve surgical precision, and provide superior value to healthcare systems by optimizing patient recovery and implant longevity. The company operates globally, targeting the large and growing joint replacement market.

OrthopaedicsJoint Replacement

Technology Platform

Apollo Platform: A cloud-connected ecosystem for robotic-assisted orthopaedic surgery featuring AI-driven preoperative planning (BalanceBot), handheld robotic cutting guides (Apollo Robot), and intraoperative validation tools. The platform integrates with Corin's implant portfolio and uses cloud computing for continuous data collection and learning across the surgical journey.

Funding History

1
UndisclosedUndisclosed

Opportunities

The rapid growth of the robotic-assisted surgery market and the large, aging demographic requiring joint replacements present a significant expansion opportunity.
Corin's integrated implant-and-platform approach offers a unique value proposition to hospitals seeking improved outcomes and operational efficiency, allowing it to compete against both traditional implant makers and pure-play robotics firms.

Risk Factors

Intense competition from larger, better-resourced medical device giants and the challenge of proving the cost-effectiveness of robotic systems in budget-constrained healthcare environments are major risks.
Execution risk in further developing and scaling its complex technology platform, including software and data management, is also significant.

Competitive Landscape

Corin competes in the orthopaedic robotics and implants market against major players like Stryker (Mako), Zimmer Biomet (ROSA), Johnson & Johnson (VELYS), and Smith & Nephew (CORI). Its differentiation lies in combining a legacy of clinically-proven implants with a proprietary, cloud-connected robotic platform, aiming for a seamless, data-integrated surgical solution rather than a standalone robot.